Wellnex Collagen Peptides, a branded ingredient of Nitta Gelatin, showed positive effects on joint pain in a new clinical trial published in the Journal of the Science of Food in Agriculture.
In this 13-week, randomized, double-blind clinical trial, 40 participants received a 10g of Wellnex peptides daily in two 5g doses, while 20 participants received placebo, which was also administered in two 5g doses.
The porcine Wellnex Collagen Peptide group had a 63% improvement in Visual Analogue Scale (VAS), Western Ontario McMaster Universities (WOMAC) scores, and Quality of Life scores, while no improvement was indicated in the placebo group. The outcomes were similar in the group taking bovine Wellnex Collagen Peptides.
“This new study indicates that those taking Wellnex Collagen Peptides may see some improvement in joint pain. This may be great news to consumers taking non-steroidal anti-inflammatory drug (NAIDs) as therapeutic agents. They now may be able to feel some difference in joint pain by ingesting a nutritional supplement or functional food with Wellnex Collagen Peptides,” said Erika Tchang, Business Development Manager.
This study was first published online on June 24, 2014.